💰 𝐀𝐥𝐜𝐨𝐧 𝐀𝐜𝐪𝐮𝐢𝐫𝐞𝐬 𝐋𝐄𝐍𝐒𝐀𝐑 𝐭𝐨 𝐄𝐧𝐡𝐚𝐧𝐜𝐞 𝐅𝐞𝐦𝐭𝐨𝐬𝐞𝐜𝐨𝐧𝐝 𝐋𝐚𝐬𝐞𝐫...
𝐌𝐚𝐫𝐜𝐡 𝐍𝐞𝐰𝐬 𝐑𝐨𝐮𝐧𝐝 𝐔𝐩
👀 𝐀𝐥𝐜𝐨𝐧 𝐀𝐜𝐪𝐮𝐢𝐫𝐞𝐬 𝐋𝐄𝐍𝐒𝐀𝐑 𝐭𝐨 𝐄𝐧𝐡𝐚𝐧𝐜𝐞 𝐅𝐞𝐦𝐭𝐨𝐬𝐞𝐜𝐨𝐧𝐝 𝐋𝐚𝐬𝐞𝐫 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐟𝐨𝐫 𝐂𝐚𝐭𝐚𝐫𝐚𝐜𝐭 𝐒𝐮𝐫𝐠𝐞𝐫𝐲 👀
Alcon is acquiring LENSAR, Inc., including its ALLY Robotic Cataract Laser System and Streamline® software, strengthening its FLACS portfolio. The $356M deal includes $14 per share in cash, plus up to $2.75 per share based on procedure volume. FDA-cleared in 2022, ALLY is the first system enabling full FLACS in a single sterile setting. This acquisition expands Alcon’s global reach, bringing advanced laser technology to more surgeons.
👀 𝐒𝐩𝐚𝐌𝐞𝐝𝐢𝐜𝐚 𝐚𝐧𝐝 𝐕𝐢𝐬𝐢𝐨𝐧 𝐄𝐱𝐩𝐫𝐞𝐬𝐬 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐞 𝐭𝐨 𝐄𝐧𝐡𝐚𝐧𝐜𝐞 𝐎𝐩𝐭𝐨𝐦𝐞𝐭𝐫𝐢𝐬𝐭 𝐓𝐫𝐚𝐢𝐧𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐊
SpaMedica and Vision Express are offering pre-reg placements for 150 aspiring optometrists, bridging community and hospital experience.
Trainees will:
👁️ Shadow clinical teams treating cataracts & AMD
👁️ Observe surgeries like cataract & vitreo-retinal procedures
👁️ Join virtual clinics to enhance diagnostic skills
The 2.5-day placements at SpaMedica’s top-rated hospitals provide hands-on training, ensuring future optometrists gain essential patient care skills.
👀 𝐀𝐈 𝐢𝐧 𝐄𝐲𝐞𝐜𝐚𝐫𝐞 & 𝐎𝐩𝐡𝐭𝐡𝐚𝐥𝐦𝐨𝐥𝐨𝐠𝐲 𝐔𝐩𝐝𝐚𝐭𝐞
👁️ Altris AI launched its Advanced Optic Disc Analysis module, using OCT imaging to improve glaucoma detection, reduce false positives, and streamline workflows.
👁️ Oculogyx unveiled an AI-powered platform at Vision Expo East 2025, featuring GenA Eye for image analysis, automated scribing, and patient intake, plus tools for practice management and compliance.
👀 𝐇𝐞𝐫𝐞’𝐬 𝐭𝐡𝐞 𝐅𝐚𝐬𝐭𝐞𝐬𝐭 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐄𝐲𝐞𝐜𝐚𝐫𝐞 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐀𝐜𝐫𝐨𝐬𝐬 𝐭𝐡𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐎𝐯𝐞𝐫 𝐭𝐡𝐞 𝐋𝐚𝐬𝐭 5 𝐘𝐞𝐚𝐫𝐬
Eyecare remains a booming sector in the medical industry, with key players experiencing significant market cap growth over the past five years (Jan 2020 – Jan 2025). Here’s how some of the industry's top companies have performed:
👁 EssilorLuxottica – $63B growth
👁 Danaher Corporation with Leica Microsystems– $49B growth
👁 Alcon – $13B growth
👁 Glaukos Corporation – $5B growth
Driven by innovation in surgical tech, digital health, and ophthalmic devices, these companies are shaping the future of global eyecare.
👀 𝐄𝐬𝐬𝐢𝐥𝐨𝐫𝐋𝐮𝐱𝐨𝐭𝐭𝐢𝐜𝐚 𝐀𝐜𝐪𝐮𝐢𝐫𝐞𝐬 𝐂𝐞𝐥𝐥𝐯𝐢𝐞𝐰 𝐭𝐨 𝐄𝐱𝐩𝐚𝐧𝐝 𝐕𝐢𝐬𝐢𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲
EssilorLuxottica has acquired Cellview Imaging Inc., a Canadian med-tech start-up specializing in advanced retinal imaging. Cellview’s FDA & CE-approved ultra-widefield retinal camera aids early disease detection and is widely used in North America. CEO Francesco Milleri says this strengthens their ophthalmic tech portfolio, reinforcing a commitment to innovation in eye care.
